Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating mycoplasma type colpitis

A technology for mycoplasma and vaginitis, applied in the direction of drug combinations, diseases, antibacterial drugs, etc., can solve the problems of patients prone to drug resistance and affect the curative effect, so as to enhance phagocytosis and hydrolysis activity, reduce the number of mycoplasma, The effect of improving the activity of the body's immune function

Inactive Publication Date: 2015-06-10
尚乐
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Clinically, azithromycin is mainly used orally, but some patients are prone to drug resistance, which affects its curative effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Topical medications include:

[0017] The production process of the extract of Spartina alterniflora is 1) Grinding the vacuum-dried Spartina alterniflora in a pulverizer to obtain Spartina alterniflora powder, and placing Spartina alterniflora and the powder in an extraction kettle for supercritical extraction Middle; 2) Use supercritical CO2 as a solvent, and ethanol with a concentration of 60% as an entrainer; 3) Adjust the extraction kettle to control the extraction pressure at 35MPa, the temperature at 35°C, the CO2 flow rate at 9L / h, and the extraction time control In 2 hours, brown paste Spartina alterniflora extract was obtained.

[0018] The dosage is expressed in parts by weight, 30 parts of Spartina alterniflora extract, 8 parts of Panax notoginseng extract, 115 parts of semi-synthetic fatty acid glyceride as the suppository base material, melt the suppository base material in a water bath, condense to room temperature, and add Spartina alterniflora to extrac...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses medicine for treating mycoplasma type colpitis. The medicine comprises external use medicine and orally-taken medicine. The external use medicine comprises 30 to 40 parts of spartina alterniflora loisel extract, 6 to 8 parts of radix notoginseng extract and 115 to 125 parts of suppository matrix materials. The orally-taken medicine comprises wheat germs, maize germs, Chinese brake herb, poria cocos, rhizoma atractylodis macrocephalae and cyperus rotundus which are all mixed and finely ground, a mixture is screened through a screen of ten meshes, coarse and large raw materials are removed, and therefore raw materials are acquired; water is added to and evenly mixed with the mixture, the mixture is homogenized through homogenizers of 20 MPa, spray drying is then conducted on the mixture, and powdery particles are acquired; cellulose is added so as to achieve primary enzymolysis, the temperature is kept between 70 DEG C and 75 DEG C in the process and maintained for 100 minutes, and enzymatic hydrolysate is acquired; the temperature is increased rapidly to 100 DEG C, maintained for 5 minutes and then rapidly reduced to 65 DEG C to 70 DEG C, the mixture is homogenized through the five homogenizers sequentially, spray drying is then conducted, and finally powdery particles are acquired. The medicine is used externally and taken orally, so that the treatment effect on mycoplasma type colpitis is good.

Description

technical field [0001] The invention relates to a medicine for treating mycoplasma vaginitis. Background technique [0002] At present, mycoplasma infection has become one of the common causes of gynecological inflammation. It can not only cause vaginitis, cervicitis and cervical erosion, but also affect fertility. The detection of mycoplasma is very important. The conventional secretion culture takes a long time and the positive rate is low. Limits its rapid diagnosis. The incidence of mycoplasma vaginitis has gradually increased in recent years. The treatment of modern medicine is mainly to kill mycoplasma, reduce inflammation and reduce the sequelae of infection. Oral azithromycin is commonly used clinically, but some patients are prone to drug resistance, which affects its curative effect. Contents of the invention [0003] Aiming at the above-mentioned problems in the prior art, the present invention provides a medicine for treating mycoplasma vaginitis, which has g...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/01A61P15/02A61P31/04
Inventor 尚乐
Owner 尚乐
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com